Technical Analysis for CARA - Cara Therapeutics, Inc.

Grade Last Price % Change Price Change
grade C 16.59 -1.60% -0.27
CARA closed down 1.6 percent on Friday, June 22, 2018, on approximately normal volume.
16 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Down
See historical CARA trend table...

Date Alert Name Type % Chg
Jun 20 Doji - Bullish? Reversal -0.30%
Jun 20 Outside Day Range Expansion -0.30%
Jun 19 MACD Bearish Signal Line Cross Bearish -0.18%
Jun 19 NR7 Range Contraction -0.18%
Jun 18 Wide Bands Range Expansion -2.01%
Jun 15 Spinning Top Other -1.25%
Jun 15 Wide Bands Range Expansion -1.25%
Jun 14 Wide Bands Range Expansion -1.01%
Jun 13 Shooting Star Candlestick Bearish -1.60%
Jun 13 Lizard Bearish Bearish Day Trade Setup -1.60%

Older signals for CARA ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Read My Charts!
Configure default chart indicators
Basic chart:
Profile
Cara Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics to treat pain. Its products include intravenous CR845 that has completed Phase II clinical trials for the treatment of acute postoperative pain in adult patients; Oral CR845, which is in Phase I clinical trials to treat acute and chronic pain; and CR701 that is in preclinical trials for treating neuropathic and inflammatory pain. The company was founded in 2004 and is based in Shelton, Connecticut.
Is CARA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Jun 21 Complimentary Technical Snapshots on Celgene and Three More Biotech Stocks
Jun 21 Factors of Influence in 2018, Key Indicators and Opportunity within Camden National, Cara Therapeutics, Albany International, Emerge Energy Services LP, Fiesta Restaurant Group, and Resources Connection — New Research Emphasizes Economic Growth
Jun 20 These companies’ drugs can boost your investment returns by reducing opioid abuse
Jun 19 Implied Volatility Surging for Cara Therapeutics (CARA) Stock Options
Jun 14 Here's Why Cara Therapeutics Jumped 26.3% in May
Jun 10 Better Marijuana Stock: GW Pharmaceuticals vs. Cara Therapeutics
Jun 7 Where Will Cara Therapeutics, Inc. Be in 5 Years?
Jun 5 Tricida readies IPO
May 30 Biotech Stock Roundup: GILD Epclusa's China Approval, BMRN Palynziq's FDA Nod
May 30 Jim Cramer Advises His Viewers On Groupon, Adobe And More
See more CARA news...
Indicators
Indicator Value
52 Week High 28.5
52 Week Low 11.12
Average Volume 1,124,069
200-Day Moving Average 13.3207
50-Day Moving Average 14.1246
20-Day Moving Average 16.323
10-Day Moving Average 16.719
Average True Range 0.7555
ADX 44.39
+DI 28.45
-DI 9.83
Chandelier Exit (Long, 3 ATRs ) 15.2335
Chandelier Exit (Short, 3 ATRs ) 15.4765
Upper Bollinger Band 17.3608
Lower Bollinger Band 15.2852
Percent B (%b) 0.63
BandWidth 12.7158
MACD Line 0.7792
MACD Signal Line 0.8635
MACD Histogram -0.0843
Fundamentals Value
Market Cap 540.51 Million
Num Shares 32.6 Million
EPS -2.28
Price-to-Earnings (P/E) Ratio -7.28
Price-to-Sales 424.16
Price-to-Book 3.54
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 17.36
Resistance 3 (R3) 17.42 17.24 17.23
Resistance 2 (R2) 17.24 17.04 17.20 17.18
Resistance 1 (R1) 16.91 16.92 16.82 16.85 17.14
Pivot Point 16.73 16.73 16.68 16.69 16.73
Support 1 (S1) 16.40 16.53 16.31 16.34 16.04
Support 2 (S2) 16.22 16.41 16.18 16.00
Support 3 (S3) 15.89 16.22 15.95
Support 4 (S4) 15.83